Women's health Clinical Trials in Dallas, TX

As of September 2026, 61 paid clinical trials are recruiting for Women's health in Dallas, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

62 clinical trials for Women's health

·Clear filters·

Email me when a new women's health trial opens in Dallas, TX.

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

for Fallopian Tube Endometrioid Adenocarcinoma

Drug: Bevacizumab

Sites in Dallas, Richardson +653 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT06580314·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

for Cervical Cancer

Sites in Dallas, Bedford +115 more locations

Sponsor: GOG Foundation

Sex: Female·Age: 18+

Code: NCT04831580·Recruiting·Listed Apr 2021

Apply to this trial

Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib

for Breast Cancer

2 locations in Dallas

Sponsor: University of Texas Southwestern Medical Center

Sex: Female·Age: 18+

Code: NCT04614194·Phase 2·Recruiting·Listed Nov 2020

Apply to this trial

Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial

for Breast Cancer

1 location in Dallas

Sponsor: University of Texas Southwestern Medical Center

Sex: Female·Age: 18+

Code: NCT06444269·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

for Breast Cancer

Sites in Dallas, San Antonio +5 more locations

Sponsor: SCRI Development Innovations, LLC

Sex: All·Age: 18+

Code: NCT05748834·Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)

for Cervix Cancer

1 location in Dallas

Sponsor: University of Texas Southwestern Medical Center

Sex: Female·Age: 18+

Code: NCT06266338·Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

Susan G. Komen's ShareForCures

for Breast Cancer

1 location in Dallas

Sponsor: Susan G. Komen Breast Cancer Foundation

Sex: All·Age: 18+

Code: NCT05654246·Recruiting·Listed Dec 2022

Apply to this trial

Converting HR+ Breast Cancer Into an Individualized Vaccine

for Breast Cancer

Sites in Dallas, Houston +3 more locations

Sponsor: Weill Medical College of Cornell University

Sex: Female·Age: 18 - 90

Code: NCT03804944·Phase 2·Recruiting·Listed Jan 2019

Apply to this trial

GammaPod Registry and Quality of Life Nomogram

for Breast Cancer Female

Sites in Dallas +3 more locations

Sponsor: University of Maryland, Baltimore

Sex: Female·Age: 18+

Code: NCT03562273·Recruiting·Listed Jun 2018

Apply to this trial

Tirzepatide Weight Loss for MRD+ Early Breast Cancer

for Breast Cancer

Drug: Tirzepatide

1 location in Dallas

Sponsor: Baylor Research Institute

Sex: All·Age: 18+

Code: NCT06517212·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC

for Breast Cancer

1 location in Dallas

Sponsor: Baylor Research Institute

Sex: Female·Age: 18+

Code: NCT04265872·EARLY_Phase 1·Recruiting·Listed Feb 2020

Apply to this trial

Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy

for Breast Cancer

1 location in Dallas

Sponsor: Deborah Farr, MD

Sex: Female·Age: 18 - 80

Code: NCT05245812·Recruiting·Listed Feb 2022

Apply to this trial

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

for Ovarian Cancer

Sites in Dallas +1 more location

Sponsor: Hefei TG ImmunoPharma Co., Ltd.

Sex: All·Age: 18+

Code: NCT05746897·Phase 1·Recruiting·Listed Feb 2023

Apply to this trial

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

for Metastatic Triple-Negative Breast Carcinoma

Drug: Ruxolitinib

1 location in Dallas

Sponsor: Baylor Research Institute

Sex: Female·Age: 18+

Code: NCT06008275·EARLY_Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

for HNSCC

Sites in Dallas, Houston +16 more locations

Sponsor: Normunity AccelCo, Inc.

Sex: All·Age: 18+

Code: NCT07182149·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

DESTINY-PANTUMOUR04

for Adenocarcinoma (NOS)

Sites in Dallas +17 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT07124000·Recruiting·Listed Aug 2025

Apply to this trial

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

for Non-small Cell Lung Cancer

Sites in Dallas, Houston +16 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06218914·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for Breast Cancer

Drug: Durvalumab

Sites in Dallas, Sugar Land +34 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06103864·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

for Breast Cancer

Sites in Dallas, Houston +10 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT05307705·Phase 1·Recruiting·Listed Apr 2022

Apply to this trial

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

for Melanoma (Skin)

Sites in Dallas, San Antonio +3 more locations

Sponsor: Hummingbird Bioscience

Sex: All·Age: 18+

Code: NCT06956690·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

for Triple Negative Breast Cancer

Sites in Dallas, Austin +8 more locations

Sponsor: Dren Bio

Sex: All·Age: 18+

Code: NCT06999187·Phase 1·Recruiting·Listed May 2025

Apply to this trial

Conditions in Women's health (Dallas, TX)

Breast cancer· 40 Endometrial cancer· 16 Ovarian cancer· 14 Cervical cancer· 8 Fallopian tube cancer· 5 Endometriosis· 1 Infertility· 1